Corona Remedies Board Meeting on July 31 for Unaudited Financial Results

Corona Remedies Ltd has announced that its Board of Directors will convene on July 31, 2026. The primary agenda for this meeting is to consider and approve the company's Unaudited Financial Results for the first quarter and three months ended June 30, 2026. Both standalone and consolidated results will be reviewed. The trading window for the company's securities will remain closed until August 02, 2026, following an earlier intimation regarding insider trading regulations.